These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11824443)

  • 1. NSAIDs and heart failure.
    Prescrire Int; 2001 Dec; 10(56):182-3. PubMed ID: 11824443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drugs in patients with cardio- or cerebrovascular disorders.
    Stöllberger C; Finsterer J
    Z Kardiol; 2003 Sep; 92(9):721-9. PubMed ID: 14508588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular adverse effects of coxibs.
    Prescrire Int; 2002 Dec; 11(62):181-2. PubMed ID: 12472094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
    Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
    Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
    McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
    Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory agents and renal function.
    Brater DC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):33-42. PubMed ID: 12528072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
    García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
    Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.
    Stillman MJ; Stillman MT
    Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance.
    Meune C; Mourad JJ; Bergmann JF; Spaulding C
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):149-54. PubMed ID: 14608518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aspirin, angiotensin converting enzyme inhibitors and cardiac insufficiency].
    de Groote P; Aumégeat V; Meurice T; Millaire A; Lamblin N; Lablanche JM
    Arch Mal Coeur Vaiss; 2000 Feb; 93(2):167-71. PubMed ID: 10830093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced lithium toxicity in the elderly: a population-based study.
    Juurlink DN; Mamdani MM; Kopp A; Rochon PA; Shulman KI; Redelmeier DA
    J Am Geriatr Soc; 2004 May; 52(5):794-8. PubMed ID: 15086664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations.
    Goltsov A; Maryashkin A; Swat M; Kosinsky Y; Humphery-Smith I; Demin O; Goryanin I; Lebedeva G
    Eur J Pharm Sci; 2009 Jan; 36(1):122-36. PubMed ID: 19028575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
    Giovanni G; Giovanni P
    J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
    Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
    Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
    J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.